American Society of Bone Marrow Transplantation (ASBMT) Oral Presentation: Viralym-C

Safety and Preliminary Efficacy of “Ready to Administer” Cytomegalovirus (CMV)-specific T Cells for the Treatment of Patients with Refractory CMV Infection.
(Abstract 34. ASBMT – 2017 BMT Tandem Meetings)